Wu et al. proposed a five lncRNA signature (lncRNA-LET, PVT1, PANDAR, PTENP1, and linc00963) that could act as a biomarker for the diagnosis of clear cell renal cell carcinoma [42]. Here, PANDAR is linked to clear cell renal carcinoma.